Objective: To study the epidemiological, clinical and paraclinical
particularities of fatty liver disease in patients with metabolic syndrome. Patients
and Method: This was a cross-sectional and analytical study carried out
over a period of seven months, from February 1 to September 30, 2019, in the
outpatient services of Gastroenterology and Metabolic and Endocrine Diseases of
the Brazzaville University Hospital. It interested all patients with metabolic
syndrome, according to the criteria of the FID harmonized in 2009, namely known
diabetic and hypertensive patients, having abdominal obesity. Results: The variables studied were socio-demographic,
clinical, morphological and biological. The search for fatty liver was
done using an abdominal ultrasound. Results: During the study period, 124
patients with metabolic syndrome were included. The average age of the
population was 52.8 ± 12 years with extremes ranging from 30 and 84 years. The
population was mainly female with a Sex-Ratio of 2.54 (F/M). The frequency of
fatty liver disease was 38.7%. The frequency of dyslipidemia was high in the
study. Conclusion: The prevalence of hepatic steatosis is high in
patients with metabolic syndrome at Brazzaville University Hospital. The
gender, lack of occupation and high level of education were the factors
associated with fatty liver disease.